These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 15342309)

  • 41. Does cardiac resynchronisation therapy improve survival and quality of life in patients with end-stage heart failure?
    Turley AJ; Raja SG; Salhiyyah K; Nagarajan K
    Interact Cardiovasc Thorac Surg; 2008 Dec; 7(6):1141-6. PubMed ID: 18541605
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Improved septal contraction and coronary flow velocity after cardiac resynchronization therapy elucidated by strain imaging and pulsed wave Doppler echocardiography.
    Kayano H; Ueda H; Kawamata T; Miyoshi F; Toshida T; Watanabe N; Hirano Y; Kawamura M; Asano T; Kou S; Tanno K; Ozawa M; Kobayashi Y; Katagiri T
    J Cardiol; 2006 Feb; 47(2):51-61. PubMed ID: 16515355
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reduced ejection fraction, sudden cardiac death, and heart failure death in the mode selection trial (MOST): implications for device selection in elderly patients with sinus node disease.
    Sweeney MO; Hellkamp AS; Ellenbogen KA; Lamas GA
    J Cardiovasc Electrophysiol; 2008 Nov; 19(11):1160-6. PubMed ID: 18554201
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neurohormonal and inflammatory markers as predictors of short-term outcome in patients with heart failure and cardiac resynchronization therapy.
    Glick A; Michowitz Y; Keren G; George J
    Isr Med Assoc J; 2006 Jun; 8(6):391-5. PubMed ID: 16833167
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Electrocardiographic remodeling during cardiac resynchronization therapy.
    Boriani G; Biffi M; Martignani C; Ziacchi M; Saporito D; Grigioni F; Domenichini G; Valzania C; Diemberger I; Bertini M; Specchia S; Branzi A
    Int J Cardiol; 2006 Apr; 108(2):165-70. PubMed ID: 15923048
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cardiac resynchronisation therapy: evidence based benefits and patient selection.
    Albouaini K; Egred M; Rao A; Alahmar A; Wright DJ
    Eur J Intern Med; 2008 May; 19(3):165-72. PubMed ID: 18395159
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Assessment of heart failure and left ventricular systolic dysfunction after cardiac pacing in patients with preserved left ventricular systolic function.
    Kachboura S; Ben Halima A; Fersi I; Marrakchi S; Zouaoui W; Kammoun I
    Ann Cardiol Angeiol (Paris); 2008 Feb; 57(1):29-36. PubMed ID: 18062936
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cardiac resynchronization therapy for heart failure.
    Bax JJ; Van der Wall EE; Schalij MJ
    N Engl J Med; 2002 Nov; 347(22):1803-4; author reply 1803-4. PubMed ID: 12456861
    [No Abstract]   [Full Text] [Related]  

  • 49. Recognition and management of congestive heart failure.
    Frankl WS
    Geriatrics; 1981 Jul; 36(7):92-102. PubMed ID: 7239168
    [No Abstract]   [Full Text] [Related]  

  • 50. The middle child in heart failure: heart failure with mid-range ejection fraction (40-50%).
    Lam CS; Solomon SD
    Eur J Heart Fail; 2014 Oct; 16(10):1049-55. PubMed ID: 25210008
    [No Abstract]   [Full Text] [Related]  

  • 51. Device therapy in patients with heart failure and preserved ejection fraction (HFPEF): a new frontier?
    Maass AH; van Veldhuisen DJ
    Eur J Heart Fail; 2010 Jun; 12(6):527-9. PubMed ID: 20498266
    [No Abstract]   [Full Text] [Related]  

  • 52. Resynchronization therapy is an important advance in the management of congestive heart failure: view of an antagonist.
    Jessup M
    J Cardiovasc Electrophysiol; 2003 Sep; 14(9 Suppl):S30-4. PubMed ID: 12950515
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cardiac-resynchronization therapy.
    Daubert C; Leclercq C
    N Engl J Med; 2008 Apr; 358(17):1865; author reply 1865-6. PubMed ID: 18434658
    [No Abstract]   [Full Text] [Related]  

  • 54. [Biventricular stimulation, an alternative therapy in the management of terminal cardiac insufficiency].
    Marlier D; Hamattit M; Honoré C
    Soins; 2004 May; (685 Suppl):16-9. PubMed ID: 15233058
    [No Abstract]   [Full Text] [Related]  

  • 55. Diuretics or ultrafiltration in the treatment of congestive cardiac failure?
    Simpson IA; Hutton I
    Br J Hosp Med; 1987 Feb; 37(2):144-5, 148. PubMed ID: 3828629
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Current pharmacotherapy of heart insufficiency in old age].
    Bertel O; Marx B; Nägeli B
    Ther Umsch; 1989 Jan; 46(1):15-21. PubMed ID: 2922690
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cardiac resynchronization therapy for congestive heart failure.
    Wijetunga M; Strickberger SA
    Expert Rev Cardiovasc Ther; 2005 Jan; 3(1):107-10. PubMed ID: 15723579
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Cardiac resynchronization in congestive heart failure: role of Doppler echocardiography in patient selection].
    Taieb J; Barnay C; Benchaa T; Moudni F; Foltzer E; Chostakoff F; Coste A; Pochon P; Jouve B; Rahal Y
    Ann Cardiol Angeiol (Paris); 2003 Dec; 52(6):353-7. PubMed ID: 14752917
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Heart failure in elderly patients].
    Hunziker P; Bertel O
    Praxis (Bern 1994); 1995 Oct; 84(44):1272-6. PubMed ID: 7491451
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Current concepts and pharmacologic treatment of heart failure.
    Capriotti T
    Medsurg Nurs; 2002 Apr; 11(2):71-83; quiz 84. PubMed ID: 11962171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.